๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above
NCT06645665Respiratory Syncytial Virus Infections
Shenzhen Shenxin Biotechnology Co., Ltd
Phase 1
240
Shanghai, Kunming
2024-11-11
Active, closed
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
NCT06719141Developmental and Epileptic Encephalopathy
Longboard Pharmaceuticals
Phase 3
367
Beijing, Guangzhou, Shenzhen Shi, Wuhan, Shanghai Shi
2024-11-11
Active, closed
Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment
NCT06523764Helicobacter Pylori Infection Chronic Gastrit
Xijing Hospital of Digestive Diseases
Phase 4
208
Xi'an
2024-11-11
Not yet open
Effect of an Oral Frailty Measures Intervention Programs in Institutionalized Elders
NCT06536985Frailty
Hangzhou Normal University
Not applicable
226
Hangzhou
2024-11-11
Recruiting
Electroacupuncture Regulation of Immune Cells in Herpes Zoster
NCT06643247Herpes Zoster, Electroacupuncture, Immune
First People's Hospital of Hangzhou
Not applicable
8
Hangzhou
2024-11-11
Recruiting
HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity
NCT07586215Breast Cancer Metastatic
Fudan University
Observational
100
Shanghai
2024-11-11
Recruiting
IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
NCT06647862Chronic Myelomonocytic Leukemia
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 3
170
Hefei, Beijing, Chongqing, Lanzhou, Nanning, Guangzhou, Shenzhen, Zhujiang
2024-11-11
Recruiting
An Observational Study of Coronary Microvascular Disease of China
NCT06676137Coronary Microvascular Disease
Henan Institute of Cardiovascular Epidemiology
Observational
500
Zhengzhou
2024-11-11
Recruiting
Predicting Tumor Origin Based on Deep Learning of Lymph Node Puncture Cytology
NCT06810349Lymph Nodes With Tumor Metastasis
West China Hospital
Observational
10,000
Chengdu
2024-11-11
Recruiting
A Real World Study About PMN
NCT06893328Primary Membranous Nephropathy
Wei Chen
Observational
200
Guangzhou
2024-11-11
Active, closed
Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)
NCT06594146Primary Immune Thrombocytopenia
Keymed Biosciences Co.Ltd
Phase 2
62
Tianjin
2024-11-11
Recruiting
Comparison of Electrolyte Beverages and Water as Solvents for Bowel Preparation
NCT06675227Bowel Preparation Before Colonoscopy
Third Military Medical University
Not applicable
2,766
Chongqing
2024-11-11
Recruiting
A Study of Olverembatinib in SDH-deficient GIST.
NCT06640361GIST
Ascentage Pharma Group Inc.
Phase 3
40
Guangzhou
2024-11-11
By invitation
GCB-002 in Treatment of Patients With Rett Syndrome
NCT06739434RETT Syndrome With Proven MECP2 Mutation
Genecombio Ltd.
Not applicable
6
Shanghai
2024-11-11
Recruiting
Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery
NCT06673498Thrombocytopenia
Anhui Provincial Hospital
Phase 2
60
Fuyang, Hefei
2024-11-10
Recruiting
Evaluating the Short-term Efficacy of Two Oscillation Techniques in Hypersecretive Mechanically Ventilated Patients
NCT06675942Hypersecretive Mechanically Ventilated Patients
Capital Medical University
Not applicable
24
Beijing
2024-11-10
Recruiting
Model-Driven Individualized Transcranial Direct Current Stimulation for the Treatment of Insomnia Disorders
NCT06671457Insomnia
Zhen Wang
Not applicable
40
Shanghai
2024-11-10
Recruiting
Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL
NCT06682130Diffuse Large B-cell Lymphoma(DLBCL)
The First Affiliated Hospital of Soochow University
Phase 2
40
Suzhou
2024-11-10
Not yet open
Placebo Response of Different Types of Sham Acupuncture for Knee Osteoarthritis
NCT06675981Knee Osteoarthritis
West China Hospital
Not applicable
150
Nanchang, Chengdu
2024-11-10
Active, closed
Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery.
NCT06772272Perioperative Anemia
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
158
Hangzhou
2024-11-10
Recruiting
A Randomized Controlled Trial of a Web-based Platform for Cancer Pain Management
NCT06663956Cancer Pain
West China Hospital
Phase 3
100
Chengdu
2024-11-10
Recruiting
The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors
NCT06911710Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL), AML (Acute Myelogenous Leukemia), Myeloma Multiple, B-ALL
Tianjin Medical University General Hospital
Phase 1/2
90
Tianjin
2024-11-09
Recruiting
Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer
NCT06658080Breast Cancer Metastatic, Hydrothorax, Ascites, Organoids
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
90
Hangzhou
2024-11-09
Recruiting
Study on Hibernation-like Therapy Based on Mechanical Thrombectomy
NCT06663631Acute Ischemic Stroke
Capital Medical University
Phase 1
32
Linyi
2024-11-09
Recruiting
Study on the Molecular Mechanism of Berberine to Improve Type 2 Diabetes Mellitus Complicated With Depression
NCT06979440Diabetes-Related Complications
Affiliated Hospital of Nantong University
Observational
40
Nantong
2024-11-09
Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy
NCT06597539Hepatobiliary Malignancy
Ruijin Hospital
Observational
40
Shanghai
2024-11-09
Recruiting
Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
NCT06867991Anti-N-Methyl-D-Aspartate Receptor Encephalitis
The First People's Hospital of Changzhou
Phase 3
200
Zhengzhou, Changzhou
2024-11-08
Recruiting
Safety Study of CC312 in Autoimmune Disease Patients
NCT06888960Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathy (IIM), Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA)
CytoCares Inc
Phase EARLY_PHASE1
18
Tianjin
2024-11-08
Recruiting
Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer
NCT06468280Gastric Cancer, GastroEsophageal Cancer
Shanghai Zhongshan Hospital
Phase 2
84
Shanghai
2024-11-08
Recruiting
Baricitinib in the Treatment of Intestinal Behรงet's Syndrome
NCT06849908Behcet Syndrome, Intestinal Type
Peking Union Medical College Hospital
Phase 2
56
Beijing
2024-11-08
Recruiting
Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT)
NCT06605209Peripheral Artery Disease (PAD)
Zhejiang Zylox Medical Device Co., Ltd.
Not applicable
130
Beijing
2024-11-08
Active, closed
A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer
NCT06614192Metastatic Colorectal Cancer
AbbVie
Phase 3
74
2024-11-08
Active, closed
A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors
NCT06610227Advanced Solid Tumors
NING LI
Phase EARLY_PHASE1
18
Beijing
2024-11-08
Recruiting
A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation
NCT06667544KRAS G12D Mutation
Ranok Therapeutics (Hangzhou) Co., Ltd.
Phase 1/2
152
Nanning, Zhengzhou, Wuhan, Hangzhou, Shanghai
2024-11-08
By invitation
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
NCT06901622Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
The First Affiliated Hospital of Zhengzhou University
Phase 2
50
Zhengzhou
2024-11-08
Recruiting
A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease
NCT06619613Alzheimer Disease
Keymed Biosciences Co.Ltd
Phase 1
48
Hefei
2024-11-08
Not yet open
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).
NCT06606509Type1 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University
Observational
1,000
Anqing, Bengbu, Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Quanzhou
2024-11-07
Recruiting
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4ฮฑ srRNA in Treating Advanced ICC Patients
NCT06583993Intrahepatic Cholangiocarcinoma
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
9
Shanghai
2024-11-07
Recruiting
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
NCT06825182Type 2 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University
Phase 3
1,000
Nanjing
2024-11-07
Recruiting
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
NCT06548971Acute Ischemic Stroke, Cerebral Infarction
Capital Medical University
Phase 3
1,184
Bengbu, Suzhou, Beijing, Haidian, Pinggu, Tongzhou, Fuzhou, Xiamen
2024-11-07
Active, closed
Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors
NCT06849921Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors, Hematologic Disease
Ruijin Hospital
Not applicable
200
Shanghai
2024-11-07
Recruiting
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer
NCT06755684EGFR, Non-Small Cell Lung Cancer, Locally Advanced Non-Small Cell Lung Cancer, Pemetrexed
Peng Zhang
Phase 2
60
Shanghai
2024-11-07
Active, closed
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
NCT06676319Asthma
Sanofi
Phase 2
556
Beijing, Changchun, Chengde, Chengdu, Foshan, Guangzhou, Guiyang, Hangzhou
2024-11-07
Recruiting
Prospective Observational Study on Comprehensive Effects of PEEK Cranioplasty and Titanium Cranioplasty After DC๏ผˆRECEPT-DC๏ผ‰
NCT05416684Skull Defect
RenJi Hospital
Observational
358
Shanghai
2024-11-07
Active, closed
A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT06668961Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
48
Shanghai
2024-11-07
Recruiting
Evaluation of Long-term Isokinetic Training of Knee Joint
NCT06674473Knee Injuries and Disorders
Peking University Third Hospital
Not applicable
12
Beijing
2024-11-06
Recruiting
Seniors Integrated Longitudinal cardioVascular Evaluation of Coronary Heart Disease: a Multicenter, Prospective Registry in China (SILVER-China)
NCT06880575Coronary Arterial Disease (CAD), ELDERLY PEOPLE
Beijing Hospital
Observational
10,139
Beijing
2024-11-06
Active, closed
Using a Novel Balloon-shaped Large-Focal Pulsed Field Ablation Catheter in Persistent Atrial Fibrillation
NCT07294742Persistent Atrial Fibrillation
The Third People's Hospital of Chengdu
Not applicable
34
Chengdu
2024-11-06
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
NCT06566586B-cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
80
Beijing, Lanzhou, Guangzhou, Guigang, Nanning, Harbin, Anyang, Puyang
2024-11-06
Active, closed
An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)
NCT06594094Duchenne Muscular Dystrophin (DMD)
HuidaGene Therapeutics Co., Ltd.
Phase EARLY_PHASE1
4
Shanghai
2024-11-06
Recruiting
Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC
NCT06817525Triple-negative Breast Cancer
Henan Cancer Hospital
Phase 2
64
Zhengzhou
2024-11-06
Recruiting
89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study
NCT06750419Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
82
Beijing, Hangzhou, Hubei, Shanghai, Suzhou, Tianjin, Wuxi, Zhejiang
2024-11-06
By invitation
A Multicenter Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor
NCT06664970MDS
Peking Union Medical College Hospital
Phase 2
39
Beijing
2024-11-06
Recruiting
RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL
NCT06674096Double-expressor Lymphoma
Zhejiang Cancer Hospital
Phase 2
44
Hangzhou
2024-11-06
Recruiting
Non-Helium Magnetoencephalography in Pediatric Brain Tumors
NCT06943742Pediatric Brain Tumor
Guangzhou Women and Children's Medical Center
Observational
100
Guangzhou
2024-11-05
Not yet open
Effect of Bupivacaine Liposomes or Bupivacaine for Femoral Triangle or Adductor Block on Analgesia After Total Knee Replacement
NCT06653621Knee Arthropathy, Knee Arthritis
Huazhong University of Science and Technology
Phase 4
144
Wuhan
2024-11-05
Recruiting
Non-Helium Magnetoencephalography in Pediatric Refractory Epilepsy
NCT07064421Refractory Epilepsy in Children
Guangzhou Women and Children's Medical Center
Observational
100
Guangzhou
2024-11-05
Recruiting
Non-Helium Magnetoencephalography in Autism Spectrum Disorder
NCT07064967Autism Spectrum Disorder (ASD)
Guangzhou Women and Children's Medical Center
Observational
80
Guangzhou
2024-11-05
Recruiting
A Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of HRS-4508 Monotherapy in Patients With Advanced or Metastatic Solid Tumors
NCT06598735Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
290
Beijing
2024-11-05
Recruiting
Efficacy and Safety of ENN0403 in Patients At High Risk for Acute Kidney Injury Following Elective Cardiac Surgery
NCT06632613Cardiac Surgery Associated - Acute Kidney Injury
EnnovaBio
Phase 2
200
Shanghai
2024-11-05
Active, closed
Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
NCT06601504Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Hutchmed
Phase 2
61
Fuzhou, Guangzhou, Nanning, Wuhan, Harbin, Zhengzhou, Changsha, Nanchang
2024-11-05
Recruiting
SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy
NCT06676722Nasopharyngeal Cancinoma (NPC), SBRT, Immunotherapy
The First Affiliated Hospital of Xiamen University
Phase 2
20
Xiamen
2024-11-05
Not yet open
A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
NCT06672393Psoriasis
Hansoh BioMedical R&D Company
Phase 3
375
Shanghai
2024-11-04
Recruiting
Clinical Performance of Urine HPV Testing in Males
NCT06671210HPV, Self-sampling, Male
Peking University People's Hospital
Observational
150
Beijing
2024-11-04
Recruiting
Evaluating Modulation Effects of Temporal Interference Using SEEG
NCT06663969Deep Brain Stimulation, Drug Resistant Epilepsy
Xuanwu Hospital, Beijing
Not applicable
20
Beijing
2024-11-04
Recruiting
Clinical Specialty Queue For Gestational Trophoblastic Neoplasia
NCT06681259Gestational Trophoblastic Neoplasia
Women's Hospital School Of Medicine Zhejiang University
Observational
1,000
Zhengjiang
2024-11-04
Recruiting
A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
NCT06639347Advanced Urothelial Carcinoma
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
90
Guangzhou
2024-11-04
Recruiting
A Phase I Study of CFT8919 in Patients With Advanced NSCLC
NCT06641609Non-Small Cell Lung Cancer With EGFR Mutation
Betta Pharmaceuticals Co., Ltd.
Phase 1
166
Hangzhou
2024-11-04
Recruiting
CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors
NCT06735495B-Cell Lymphoblastic Leukemia/Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1/2
80
Wuhan
2024-11-04
Not yet open
A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Chinese Healthy Male Subjects
NCT06641388Healthy Subjects (HS)
Akeso
Phase 1
180
Changsha
2024-11-04
Recruiting
Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC)
NCT07359235Bladder Cancer (BC)
Tongji Hospital
Phase 1
29
Wuhan
2024-11-04
Recruiting
All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer๏ผša Multi-center, Multi-cohort Phase II Trial
NCT06636981Triple Negative Breast Cancer (TNBC)
Fudan University
Phase 2
129
Shanghai
2024-11-04
Recruiting
Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage
NCT06673602Cognitive Impairment, Intracerebral Hemorrhage
Qinhuangdao Hospital of Traditional Chinese Medicine
Phase 4
200
Beijing, Qinhuangdao, Kaifeng, Jinan, Weifang, Kunming
2024-11-04
Not yet open
Minimally Invasive Atlantoaxial Lateral Mass Joint Fusion (MIS-PALF) As a Surgical Treatment of Atlantoaxial Dislocation
NCT06678711Atlantoaxial Dislocation
Peking University Third Hospital
Not applicable
60
Beijing
2024-11-04
Recruiting
Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC
NCT06643793Colorectal Neoplasms Malignant
Affiliated Hospital of Nantong University
Phase 2
30
Nanjing
2024-11-04
Recruiting
Comparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown Esophagectomy
NCT07043491Esophageal Cancer, Surgery-Complications
Sun Yat-sen University
Observational
2
Guangzhou
2024-11-04
Active, closed
A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis
NCT06640257Psoriatic Arthritis
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
208
Shanghai
2024-11-04
Recruiting
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
NCT06596694Gastrointestinal Cancer
Merck Sharp & Dohme LLC
Phase 1/2
180
Hefei, Fuzhou, Xiamen, Guangzhou, Nanning, Zhengzhou, Shanghai, Taiyuan
2024-11-03
Recruiting
Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia
NCT07014449AML (Acute Myelogenous Leukemia, Relapsed Acute Myelogenous Leukemia, Refractory Acute Myeloid Leukemia, Hematologic Malignancy
Hangzhou Weben Pharma Co., Ltd
Phase 1
18
Hangzhou
2024-11-03
By invitation
Local Hyperthermia for the Treatment of Cervical Persistent High-risk Infection
NCT07059819Cervical Intraepithelial Neoplasia (CIN), Human Papillovirus
First Hospital of China Medical University
Not applicable
400
Shenyang
2024-11-02
Not yet open
A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Negative Driver Genes (IVO BRAIN)
NCT06684873NSCLC, Brain Metastasases
Sun Yat-sen University
Phase 2
55
Guangzhou
2024-11-02
Recruiting
Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
NCT07483151Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
Zhuan Zhang
Observational
110
Yangzhou
2024-11-01
Recruiting
Personalized Ultrasound-Guided External Diaphragm Pacing to Improve Outcomes in Invasive Mechanically Ventilated Patients
NCT06609577Respiratory Failure, Mechanical Ventilation
Daishan Jiang
Not applicable
150
Nantong
2024-11-01
Recruiting
Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer
NCT06826079Gastric Junction Adenocarcinoma, Gastric Cancer, Immunotherapy, Neoadjuvant Therapies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
86
Wuhan
2024-11-01
Recruiting
Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.
NCT06563999Lung Cancer Stage III, Mutation
Sun Yat-sen University
Phase 2
120
Guangzhou
2024-11-01
By invitation
The Effectiveness of Interventions Targeting Self-Perception of Aging in Older Adults with Subjective Cognitive Decline
NCT06622889Subjective Cognitive Decline (SCD)
Zheng Li
Not applicable
64
Beijing
2024-11-01
Recruiting
Clinical Study of SMILE 4.0-VISULYZE in Correcting Refractive Errors
NCT06982807Refractive Surgery, Myopia; Refractive Error
Affiliated Hospital of Nantong University
Not applicable
600
Nantong
2024-11-01
Recruiting
Adjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal Cancer
NCT06520683Colorectal Cancer, Microsatellite Instability High
Sun Yat-sen University
Phase 3
180
Guangzhou
2024-11-01
Recruiting
Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
NCT06684600Esophageal Squamous Cell Carcinoma
Peking University
Phase 2
35
Beijing
2024-11-01
Recruiting
Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study
NCT06848582Soft Tissue Sarcoma (STS)
Sun Yat-sen University
Not applicable
40
Guangzhou, Dongguan
2024-11-01
Active, closed
Cola Ingestion for Esophageal Bolus Impaction
NCT06652620Esophageal Cancer
Fudan University
Not applicable
50
Xiamen, Yangzhou, Jingdezhen, Shanghai
2024-11-01
Not yet open
Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer
NCT06648200Small Cell Lung Cancer Extensive Stage, Small Cell Lung Cancer Recurrent
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
100
Shanghai
2024-11-01
Recruiting
Effect of WBT for CI With Depression
NCT06968013Chronic Insomnia, Depression Disorders
Xuanwu Hospital, Beijing
Not applicable
84
Beijing
2024-11-01
Not yet open
Intelligent Analysis and Clinical Validation of Cerebral Small Vessel Disease on Magnetic Resonance Imaging๏ผšA Multi-center Study
NCT06667635Cerebral Small Vessel Disease
Chinese PLA General Hospital
Observational
1,000
Beijing
2024-11-01
Recruiting
Effects of Tai Chi on Chronic Insomnia Disorder Combined With Hyperarousal/Anxiety
NCT06967974Chronic Insomnia
Xuanwu Hospital, Beijing
Not applicable
80
Beijing
2024-11-01
Recruiting
The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults
NCT06717828Non-Alcoholic Fatty Liver Disease
Fujian Provincial Hospital
Not applicable
250
Fuzhou
2024-11-01
Recruiting
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
NCT06676449Esophageal Carcinoma, Radiotherapy, Immunotherapy
Fudan University
Phase 3
432
Shanghai
2024-11-01
Recruiting
Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients
NCT07074457CD30+ Peripheral T-cell Lymphoma
The First Affiliated Hospital of Soochow University
Not applicable
47
Suzhou
2024-11-01
Recruiting
Validating a Medical AI Fine-Tuning Platform for Major Diseases
NCT07795645Chronic Gastritis, Gastric Cancer (GC), Coronary Artery Disease, Stroke
Beijing Friendship Hospital
Observational
96,000
Beijing
2024-11-01
Recruiting
Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.
NCT06631391Neuroblastoma
Sun Yat-sen University
Phase 1
30
Guangzhou
2024-11-01
Rows per page Showing 10801–10900 of 19052
Previous 107 108 109 110 111 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=109

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.